<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04559061</url>
  </required_header>
  <id_info>
    <org_study_id>20-PR-1010</org_study_id>
    <nct_id>NCT04559061</nct_id>
  </id_info>
  <brief_title>Vektor vMap™ Clinical Validation Study</brief_title>
  <official_title>Clinical Validation of the Vektor Computational ECG Mapping System (vMap™) for Atrial and Ventricular Arrhythmias/Pacing</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vektor Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Experien Group</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Vektor Medical</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a retrospective, multi center clinical study collecting existing, de-identified&#xD;
      subject data from medical records to be analyzed using an independent core laboratory to&#xD;
      validate performance of a computational ECG mapping system (vMap™).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 1, 2020</start_date>
  <completion_date type="Actual">April 6, 2021</completion_date>
  <primary_completion_date type="Actual">April 6, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of accuracy/agreement of vMap™ in correctly identifying the ventricular chamber/region of the arrhythmia for PCV and VT.</measure>
    <time_frame>Immediately post ablation procedure through approximately 6 months post ablation procedure, based on retrospective data collection eligibility criteria.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of accuracy/agreement of vMap™ in correctly identifying the chamber/region of the arrhythmia location for all arrhythmia types.</measure>
    <time_frame>Immediately post ablation procedure through approximately 6 months post ablation procedure, based on retrospective data collection eligibility criteria.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of accuracy/agreement of vMap™ in correctly identifying the segment of the arrhythmia treatment across all arrhythmia types.</measure>
    <time_frame>Immediately post ablation procedure through approximately 6 months post ablation procedure, based on retrospective data collection eligibility criteria.</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">225</enrollment>
  <condition>Cardiac Arrhythmia</condition>
  <condition>Atrial Fibrillation</condition>
  <condition>Ventricular Arrythmia</condition>
  <condition>Premature Ventricular Complexes Multiple</condition>
  <condition>Ventricular Tachycardia</condition>
  <condition>Ventricular Fibrillation</condition>
  <condition>Premature Atrial Complex</condition>
  <condition>Atrioventricular Reentrant Tachycardia</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cardiac ablation procedure</intervention_name>
    <description>Retrospective data will be collected from cases where successful ablation was completed.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients with cardiac arrhythmia that have undergone successful ablation procedures.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patient has one of the following clinical arrhythmia/pacing types:&#xD;
&#xD;
               -  Atrial pacing&#xD;
&#xD;
               -  Atrial fibrillation&#xD;
&#xD;
               -  Ventricular pacing&#xD;
&#xD;
               -  Premature ventricular complex&#xD;
&#xD;
               -  Ventricular tachycardia&#xD;
&#xD;
               -  Ventricular fibrillation&#xD;
&#xD;
               -  Focal atrial tachycardia&#xD;
&#xD;
               -  Premature atrial complex&#xD;
&#xD;
               -  Atrioventricular reentrant tachycardia&#xD;
&#xD;
          2. Patient has undergone 'successful' routine, standard of care diagnostic&#xD;
             electrophysiology (EP) study using intracardiac catheters as clinically indicated,&#xD;
             guided by fluoroscopy and routine electroanatomic mapping, intracardiac&#xD;
             echocardiography, and/or cardiac imaging such as CT or MRI.&#xD;
&#xD;
          3. Patient has 12 lead electrogram data of clinical rhythms recorded on electrogram&#xD;
             recording system.&#xD;
&#xD;
          4. Patient has undergone a successful ablation procedure.&#xD;
&#xD;
          5. Arrhythmia type and atrial/ventricular characteristics can be abstracted from patient&#xD;
             medical records.&#xD;
&#xD;
          6. Patient was between 22 and 100 years of age at time of EP study and ablation&#xD;
             procedure.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Patients with unstable coronary artery disease, confirmed intracardiac thrombus, active&#xD;
        sepsis, complex congenital heart disease, dextrocardia, severe pulmonary hypertension,&#xD;
        decompensated heart failure, a mechanical heart valve, myocardial infarction within 1 month&#xD;
        of ablation, inability to induce arrhythmia, unacceptable ECG data quality, and/or data&#xD;
        included in the device training dataset.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chris Villongco, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Vektor Medical</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>California</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of California San Diego Health</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92093</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA San Diego Healthcare System</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92161</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sutter Health</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94107</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>September 10, 2020</study_first_submitted>
  <study_first_submitted_qc>September 21, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 22, 2020</study_first_posted>
  <last_update_submitted>April 7, 2021</last_update_submitted>
  <last_update_submitted_qc>April 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Premature Birth</mesh_term>
    <mesh_term>Atrial Fibrillation</mesh_term>
    <mesh_term>Arrhythmias, Cardiac</mesh_term>
    <mesh_term>Tachycardia</mesh_term>
    <mesh_term>Tachycardia, Ventricular</mesh_term>
    <mesh_term>Ventricular Fibrillation</mesh_term>
    <mesh_term>Ventricular Premature Complexes</mesh_term>
    <mesh_term>Atrial Premature Complexes</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

